auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Feldan Bio inc.Department
National Research Council CanadaAmount
$600.0K
Province
QCType
Contribution
Agreement Number
GC-2017-Q3-32861
Purpose
Natural killer (NK) cells play a crucial role in the control of tumors, making them appealing for immunotherapy. Alongside Green Cross LabCell, Feldan aims to genetically modify NK cells to improve their potential for allogeneic engraftment and their cytotoxicity against tumors. This project will lead to the development of universal, off-the-shelf and hyperactive NK cells for immuno-oncology therapies.
Feldan Bio inc. × National Research Council Canada
11 grants totalling $2.3M
Canadian International Innovation Program
132 grants totalling $54.2M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Optiwave Systems Inc. | $600.0K | Canadian International Innovation Progra... |
| Canadian Health Solutions Inc. | $600.0K | Canadian International Innovation Progra... |
| Precision Microdynamics Inc. | $600.0K | Canadian International Innovation Progra... |
| Aspect Biosystems Ltd. | $600.0K | Canadian International Innovation Progra... |
| 7423463 Manitoba Ltd. | $600.0K | Canadian International Innovation Progra... |